Thank you to everyone who responded to my first post a couple of months ago, regarding an extension to TCZ.
An update for you…..
As suggested by Lemonzest I’ve exchanged a few emails with Roche UK, and here’s their response:
“I have discussed your query with our Medical Affairs team and they have confirmed that unfortunately funding extensions are no longer available in the UK for RoActemra. We can only recommend that you discuss this further with your doctor as they are best placed to provide advice on how to access and obtain funding for medicines in the UK.”
So that’s that.
As regards the possibility of additional funding from my local NHS Trust, although my consultant has lobbied hard for this, the Trust has now formally refused. That’s unsurprising, but nonetheless disappointing.
So, my next step is to explore the possibility of moving to sarilumab, another IL-6 inhibitor, but that’s unlikely as I don’t think it’s been licensed for GCA yet. Unless anyone knows any different?
After that, the only possibility left is to see if I can get an extension via a private rheumy and pay for it privately.
Will keep you updated……
Written by
Duncoding
To view profiles and participate in discussions please or .
Dear Duncoding, that is really bad news - in the EU a first biosimiliar of Tocilizumab is available (TYENNE from Fresenius Kabi). It is (at least in Germany where I live) at present only moderately cheaper than Actemra (400 € less for 4 injections). I have no idea if it is approved in UK - but if so it might be worth to contact the manufacturer as you did for Roche. I generally think that biosimilars will lead to decreased prices - but we will have to see how long this takes.
I am on Sarilumab in the UK. My rheumatologist at the Hammersmith Hospital (Imperial) prescribes it and it is funded directly from them. I had my year of Tox and then had several flares and a couple of small strokes. Hence Sarilumab.
All very worrying ....I am about to come off tocilizumab after a year in the UK as an alternative to steriods.....consultant says in remission anyway altho I am not convinced.....I am relying on being able to get again if flare!! I have GCA and PMR. Anyway I wish you luck with it
I was put on Tocilizumab for temporal arteritis in 2019. I was already on Etanercept for rheumatoid arthritis which was stopped and I was told that Tocilizumab would cover both conditions. My Tocilizumab was stopped and my rheumatologist then put me on it for my rheumatoid arthritis and with a yearly review I am still on it. I am in London.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.